Sentinel Node Mapping in Endometrial Cancer with Radioactive Colloid Injection: A Feasibility Study
DOI:
https://doi.org/10.37591/rrjooh.v4i2.1369Abstract
Role of lymphadenectomy in endometrial cancer is a much-debated one. Sentinel node mapping procedure attempts to minimize the morbidity of lymphadenectomy while providing the required prognostic information. In this study, we are attempting to detect the feasibility of SLN detection in early endometrial cancer by using radioactive technetium colloid injection. This is a prospective non-randomized single-institution study where patients with apparently early endometrial cancer without enlarged lymph nodes underwent preoperative cervical injection and/or intraoperative fundal subserosal injection of Tc99m tagged with sulphur-colloid followed by assessment of radioactivity to detect the SLN. Sensitivity and detection rate were the two main endpoints of the study. 24 patients underwent the procedure during the study period with average detection rate of 75%. Fundal subserosal injection showed more sentinel nodes in the para aortic area (59%) whereas, cervical injection showed more nodes in the pelvic nodal basin (80%). The sensitivity of this technique was found to be 50%. Sentinel node mapping for early stage endometrial cancer seems to be feasible. Technique needs to be modified by combining blue dye along with technetium or adopt Indocyanine green (ICG) injection followed by fluorescent imaging to improve the sensitivity and diagnostic accuracy.
Keywords: Sentinel node mapping, endometrial cancer, subserosal injection, radioactive colloid injection
Cite this ArticleRoopesh N, Anupama Rajanbabu, Vijaykumar DK, et al. Sentinel node mapping in endometrial cancer with radioactive colloid injection– A feasibility study. Research and Reviews: Journal of Oncology and Hematology (RRJoOH). 2015; 4(2): 13–16p.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |